Genentech - A Member of the Roche Group

/ About Us / Views On Public Policy

Clinical Trial Transparency

Genentech places a high priority on ensuring that clinical trial information is available to physicians and other interested parties. To provide transparency with respect to Genentech clinical trials research, Genentech posts protocol information for all ongoing Phase I/II, II, III, and IV Genentech-sponsored trials to the National Institute of Health's (NIH) website, www.clinicaltrials.gov. In addition, we post summaries of clinical trial results for all Genentech-sponsored Phase II, III, and IV clinical trials completed after October 15, 2002 for all of our marketed products.